论文部分内容阅读
胃癌是我国目前极为常见的一种疾病,致死率较高,每年因胃癌导致死亡的比例约占恶性肿瘤患者的四分之一,处于较为严峻的形势[1]。本文采用序贯甘露聚糖肽联合泰索帝/顺铂/5FU联合化疗(DCF)方案对胃癌患者进行治疗,现将临床结果报告如下。1资料与方法1.1临床资料2011年4月至2013年5月入住我院的胃癌患者,纳入标准:患者均经统一检查后确诊为胃癌,无高血压、糖尿病等。排除标准:具有多种
Gastric cancer is a very common disease in our country with a high lethal rate. The annual death rate due to gastric cancer accounts for about one quarter of those with malignant tumors and is in a more severe situation [1]. In this paper, sequential mannan peptide combination with taxotere / cisplatin / 5FU combined chemotherapy (DCF) regimen for treatment of gastric cancer patients, the clinical results are reported below. 1 Materials and Methods 1.1 Clinical data April 2011 to May 2013 admitted to our hospital for patients with gastric cancer, inclusion criteria: patients were diagnosed after a unified gastric cancer, no high blood pressure, diabetes and so on. Exclusion criteria: There are many